Lesson 2.2 — The DIA TMF Reference Model Chapter 2 Lesson 2 30 min Interactive + Quiz Introduction

The DIA TMF Reference Model

In Lesson 2.1 you learned why the Trial Master File exists and what it protects. Now you need to understand how it is structured. Without a clear structure, a TMF is just a pile of documents. The structure is what makes it inspectable, navigable, and auditable.

The global standard for TMF structure is the DIA TMF Reference Model, published by the Drug Information Association. It is used by sponsors, CROs, and regulatory authorities around the world as the common framework for organizing clinical trial documents. Whether you work with a paper ISF or an electronic eTMF system, this model is the blueprint.

Why the DIA model matters to you: When a CRA or inspector looks at your ISF and asks for a specific document, they are thinking in terms of this model. Knowing the six zones means you can find and place documents correctly, communicate using shared language, and understand exactly what is missing when there is a gap.

Part 1

The Six Zones of the DIA TMF Reference Model

The DIA model organizes all TMF documents into six numbered zones. Each zone covers a different aspect of the trial. Click any zone button below to explore its purpose, the key documents it contains, and what happens when it is incomplete.

Zone 1 Zone 2 Zone 3 Zone 4 Zone 5 Zone 6

Zone 1 — Trial Management

Sponsor-level oversight and trial-wide governance documents

Zone 1 covers the documents that govern how the trial is managed at the sponsor and CRO level. These are the planning and oversight documents that exist before a single site is selected. They define the organizational structure, plans, and agreements that underpin the entire trial. From a site perspective, you will receive copies of many Zone 1 documents for your ISF.

Key Documents in Zone 1 Clinical Development Plan Project Management Plan Monitoring Plan Data Management Plan Safety Management Plan Communication Plan CRO contracts and agreements Trial Team training records Site relevanceAs a site team member, you will mainly see Zone 1 documents as references rather than documents you file yourself. However, you should know they exist so you understand why the CRA refers to the Monitoring Plan when conducting a visit.

Zone 2 — Central Trial Documents

The protocol, investigational product documents, and trial-wide regulatory submissions

Zone 2 contains the documents that define what the trial is and how it must be conducted. The protocol is the most important document in any clinical trial, and it lives in Zone 2. So do the Investigator's Brochure, the ethics committee submissions, and the regulatory authority approvals. Every site should have copies of all applicable Zone 2 documents in their ISF from the start of the trial.

Key Documents in Zone 2 Clinical trial protocol (all versions) Protocol amendments Investigator's Brochure (IB) Informed Consent Form templates (all versions) Ethics committee submissions and approvals Regulatory authority approvals Clinical trial registry entries Insurance and indemnity certificates Version control is critical hereEvery version of the protocol and ICF must be kept. When an amendment is issued, the old version is not discarded. It stays in the file, clearly superseded, so inspectors can see the trial's history. A site that only keeps the current version has an incomplete ISF.

Zone 3 — Site Management

Site-specific qualification, initiation, and operational documents

Zone 3 is where site-level documents live. This is the zone you will work with most directly as a clinical operations professional. It covers everything from the initial feasibility questionnaire through site qualification, initiation, and day-to-day management. The Delegation of Authority Log, staff CVs, GCP certificates, and monitoring visit reports all belong in Zone 3.

Key Documents in Zone 3 Site Feasibility Questionnaire Site Qualification Visit (SQV) report Site Initiation Visit (SIV) report and training records Delegation of Authority (DoA) Log Investigator and site staff CVs GCP training certificates for all staff Monitoring visit reports (all visits) Site correspondence (with sponsor, CRO, IRB) Protocol deviation and CAPA logs Site closure documentation This is your primary zoneIf you work at an investigational site, most of your daily filing activity goes into Zone 3. It is also the zone most frequently reviewed by CRAs during monitoring visits. A complete and current Zone 3 is the strongest indicator of a well-managed site.

Zone 4 — Investigational Product

All documents related to the study drug or device from manufacture to destruction

Zone 4 covers the complete lifecycle of the investigational product at the site, from the moment it arrives until the last unit is returned or destroyed. These documents demonstrate that the product was genuine, stored correctly, dispensed to the right participants at the right dose, and fully accounted for. A missing or incomplete Zone 4 is one of the most serious findings an inspector can make.

Key Documents in Zone 4 Investigator's Brochure (IP section) IP Certificate of Analysis (CoA) IP shipping and receipt records IP storage condition logs (temperature records) IP accountability log (dispensing and returns) IP destruction or return records Pharmacy SOP for IP handling Randomization and blinding codes (if applicable) Every unit must be accounted forThe number of units received must equal the number dispensed plus the number returned or destroyed. If these numbers do not match exactly, it is a critical finding. The IP accountability log is typically checked at every monitoring visit and must be current to the day.

Zone 5 — Subject Documents

All documents relating to individual trial participants

Zone 5 contains the documents that relate directly to the participants enrolled in the trial. These are among the most sensitive documents in the entire ISF because they contain personal health information. They must be stored securely, accessed only by authorized personnel, and protected at all times. Crucially, participant source documents remain at the site and are never sent to the sponsor.

Key Documents in Zone 5 Signed and dated Informed Consent Forms (ICFs) Subject screening log Subject enrolment log Subject identification code list (confidential) Case Report Forms (CRFs) or EDC printouts Source documents (medical records, lab results, visit notes) SAE reports for each affected participant Early withdrawal records and reasons Confidentiality and source documentsParticipant names must never appear in any document sent outside the site. All external documents use a study identification number only. Source documents never leave the site. The CRA verifies them on-site but does not take copies away with them.

Zone 6 — Monitoring

All documents produced through sponsor oversight activities

Zone 6 captures the evidence of sponsor oversight. Every monitoring visit produces a report. Every risk-based monitoring review produces a record. These documents prove that the sponsor actively supervised the trial, identified issues, and took corrective action. Without Zone 6, there is no proof that monitoring occurred, which is itself a serious GCP violation.

Key Documents in Zone 6 All monitoring visit reports (MVRs) Risk-based monitoring reports and outputs Action item tracking logs Remote monitoring contact records Audit reports (if applicable) Inspection reports from regulatory authorities Responses to audit or inspection findings Serious breach reports (if applicable) File monitoring reports as soon as they arriveMonitoring visit reports are typically sent by the CRA within 2 weeks of the visit. Many sites wait to file them, which creates a Zone 6 gap. File the report the same day it arrives and log it in your document tracker. The action items within the report should also be extracted and added to your action item log on the same day. Part 2

Sort the Documents

Interactive Activity — File These Documents

Below are 10 documents found at a clinical trial site. Click a document chip to select it, then click the correct zone below to place it. Each document belongs in exactly one zone. Try to get all 10 correct.

Documents to sort Signed Informed Consent Form GCP Training Certificate IP Temperature Log Monitoring Visit Report Protocol Amendment v2.0 Delegation of Authority Log Subject Enrolment Log IP Accountability Log Monitoring Plan SAE Report Zone 1 — Trial Management Zone 2 — Central Trial Documents Zone 3 — Site Management Zone 4 — Investigational Product Zone 5 — Subject Documents Zone 6 — Monitoring ↻ Reset Part 3

Inspect This ISF

Activity — Spot the Findings

Below is a simplified ISF status overview for a fictional site in Amman, Jordan, three months into an active Phase III trial. Each row shows the document name, its zone, and its current status. Review the ISF and click "Run Inspection" to generate the findings report.

Investigator Site File — Al-Nour Hospital, Amman Phase III Active Zone 2Protocol v3.0 (current) Present Zone 2Protocol v1.0 and v2.0 (previous versions) Missing Zone 2Ethics committee approval (current) Present Zone 2Informed Consent Form v1.0 (superseded) Missing Zone 3Delegation of Authority Log Present Zone 3PI GCP Certificate Expired Zone 3Study Nurse CV Present Zone 3Monitoring Visit Report — Visit 3 Missing Zone 4IP Accountability Log Present Zone 4IP Temperature Logs (last 30 days) Present Zone 4IP Certificate of Analysis Missing Zone 5Signed Informed Consent Forms (all participants) Present Zone 5Subject Enrolment Log Present Zone 6Monitoring Visit Reports — Visits 1 and 2 Present Zone 6Action Item Log Missing Run Inspection Report

Inspection Findings — 5 Issues Identified 1 Zone 2 — Previous protocol versions missing. Protocols v1.0 and v2.0 are absent from the ISF. All versions of the protocol must be retained to allow an inspector to trace the full history of protocol changes and verify that amendments were handled correctly. Severity: Major. 2 Zone 2 — Superseded ICF version missing. The original Informed Consent Form v1.0 is not present. Participants enrolled under this version need their consent documented against it. Its absence means the consent process for early participants cannot be verified. Severity: Major. 3 Zone 3 — PI GCP certificate expired. The Principal Investigator's GCP training certificate has expired. The PI cannot legally perform GCP-regulated activities without a valid certificate. Any activities performed since expiry may be challenged. Immediate re-training and re-certification required. Severity: Critical. 4 Zone 4 — IP Certificate of Analysis missing. The Certificate of Analysis for the investigational product is not on file. This document confirms the identity, purity, and potency of the product supplied to the site. Without it, the integrity of the IP cannot be verified. Severity: Major. 5 Zone 3 and Zone 6 — Monitoring Visit Report 3 and Action Item Log missing. The most recent monitoring visit report has not been filed. An action item log tracking outstanding findings is also absent. This makes it impossible to verify that previous monitoring findings were addressed. Severity: Major. ✓

Knowledge Check

Question 1 of 5 Score: 0 Q 01 The Delegation of Authority Log belongs in which zone of the DIA TMF Reference Model? AZone 1 — Trial ManagementZone 1 covers trial-wide management documents at the sponsor level, such as the Monitoring Plan and CRO contracts. The DoA Log is site-specific. BZone 2 — Central Trial DocumentsZone 2 contains trial-wide central documents such as the protocol, ICF templates, and ethics approvals. The DoA Log is site-specific. CZone 3 — Site ManagementCorrect. Zone 3 covers all site management documents including staff qualifications, monitoring visit reports, and the Delegation of Authority Log. DZone 5 — Subject DocumentsZone 5 contains participant-related documents such as signed informed consent forms and case report forms. Previous Next Q 02 A protocol amendment (version 3.0) is issued. The site already has versions 1.0 and 2.0 in the ISF. What is the correct action? AReplace v1.0 and v2.0 with v3.0 and discard the old versionsDiscarding old versions destroys the audit trail. An inspector needs to see every version to understand how the protocol evolved and verify each amendment was handled correctly. BFile v3.0 alongside v1.0 and v2.0, marking the earlier versions as supersededCorrect. All protocol versions must be retained in the ISF. Mark v1.0 and v2.0 as superseded and file v3.0 as the current version. All three remain in the file. CWait for the CRA to collect and file v3.0 during the next monitoring visitWaiting for the CRA to file documents is not appropriate. It is the site team's responsibility to maintain the ISF. The CRA verifies it, not maintains it. DFile only v3.0 since it is the version currently in useOnly filing the current version leaves an incomplete record. The history of protocol changes is an essential part of the TMF. Previous Next Q 03 Which zone contains documents that prove the investigational product was genuine, stored correctly, and fully accounted for? AZone 2 — Central Trial DocumentsZone 2 contains central trial documents including the protocol and ethics approvals. IP documents belong in a dedicated zone. BZone 3 — Site ManagementZone 3 covers site management documents such as staff CVs, GCP certificates, and monitoring visit reports. CZone 4 — Investigational ProductCorrect. Zone 4 is dedicated to the investigational product, covering everything from the Certificate of Analysis and shipping records through to storage logs, dispensing records, and destruction documentation. DZone 5 — Subject DocumentsZone 5 contains documents relating to individual participants, such as signed consent forms and case report forms. Previous Next Q 04 A participant's full name appears on an SAE report sent to the sponsor. Is this correct practice? AYes, the sponsor needs full identification for medical follow-upParticipant names must never appear on any document sent outside the site. Personal health information is protected and external documents must use only the participant's study identification number. BNo, only the participant's study identification number should appear on documents sent outside the siteCorrect. All external documents must identify participants by their unique study identification number only. The site keeps the Subject Identification Code List, which links numbers to names, and it never leaves the site. COnly the participant's initials should be used on external documentsInitials alone are not fully protective of participant identity in small communities. Study identification numbers are the correct approach and provide consistent, unambiguous identification. DThe SAE report should not be sent until a confidentiality agreement is signed for this specific eventSAE reports must be sent promptly to the sponsor regardless of confidentiality concerns. The correct approach is to use study identification numbers, not to delay the report. Previous Next Q 05 Which zone of the DIA TMF Reference Model is the clinical operations specialist at a site most directly responsible for maintaining on a daily basis? AZone 1 — Trial ManagementZone 1 is primarily maintained by the sponsor and CRO. Site teams receive copies of some Zone 1 documents but do not generate or maintain them. BZone 2 — Central Trial DocumentsZone 2 documents are largely generated at the sponsor level. The site receives copies but does not typically create or maintain Zone 2 documents independently. CZone 3 — Site ManagementCorrect. Zone 3 is the site management zone and is the primary responsibility of the clinical operations team at the site. CVs, GCP certificates, the DoA Log, monitoring reports, and correspondence are all Zone 3 documents maintained daily by the site team. DZone 6 — MonitoringZone 6 is primarily generated by the sponsor or CRO. Monitoring visit reports are written by the CRA and sent to the site, which files them. But the site does not generate Zone 6 documents themselves. Previous Finish Quiz 0 / 5 Try Again

Key Takeaways

1 The DIA TMF Reference Model organizes all clinical trial documents into six zones: Trial Management, Central Trial Documents, Site Management, Investigational Product, Subject Documents, and Monitoring. 2 Zone 3 is your primary responsibility as a site operations professional. It contains all site-specific documents including the DoA Log, staff CVs and GCP certificates, and monitoring visit reports. 3 All versions of documents must be kept, not just the current one. Superseding a protocol or ICF version means marking the old one as superseded, not discarding it. 4 Participant names must never leave the site. All external documents use the study identification number only. The Subject Identification Code List is confidential and remains at the site at all times. 5 The IP accountability record in Zone 4 must balance perfectly at all times: units received = units dispensed + units returned or destroyed. Any discrepancy is a critical finding. [tcb-script]/* ── ZONE EXPLORER ── */function showZone(n) { document.querySelectorAll('.zone-panel').forEach(function(p){ p.classList.remove('active'); }); document.querySelectorAll('.zone-btn').forEach(function(b){ b.classList.remove('active'); }); document.getElementById('zp-' + n).classList.add('active'); document.querySelectorAll('.zone-btn')[n-1].classList.add('active');}/* ── SORT GAME ── */// correct zone for each doc index (0-9)var CORRECT = { 0:5, 1:3, 2:4, 3:6, 4:2, 5:3, 6:5, 7:4, 8:1, 9:5 };var LABELS = { 0:'Signed Informed Consent Form', 1:'GCP Training Certificate', 2:'IP Temperature Log', 3:'Monitoring Visit Report', 4:'Protocol Amendment v2.0', 5:'Delegation of Authority Log', 6:'Subject Enrolment Log', 7:'IP Accountability Log', 8:'Monitoring Plan', 9:'SAE Report'};var selectedDoc = null;var sortCorrect = 0;function selectChip(el) { if (el.classList.contains('correct') || el.classList.contains('wrong')) return; document.querySelectorAll('.sort-chip').forEach(function(c){ c.classList.remove('selected'); }); el.classList.add('selected'); selectedDoc = el; // highlight zones document.querySelectorAll('.sort-zone').forEach(function(z){ z.classList.add('targeted'); });}function dropToZone(zoneNum) { if (!selectedDoc) return; var docId = parseInt(selectedDoc.dataset.doc); document.querySelectorAll('.sort-zone').forEach(function(z){ z.classList.remove('targeted'); }); if (CORRECT[docId] === zoneNum) { // correct selectedDoc.classList.remove('selected'); selectedDoc.classList.add('correct'); selectedDoc.onclick = null; // place chip in zone var placed = document.createElement('span'); placed.className = 'placed-chip'; placed.textContent = LABELS[docId]; document.getElementById('szb-' + zoneNum).appendChild(placed); sortCorrect++; selectedDoc = null; updateSortScore(); } else { // wrong selectedDoc.classList.remove('selected'); selectedDoc.classList.add('wrong'); var el = selectedDoc; setTimeout(function(){ el.classList.remove('wrong'); }, 600); selectedDoc = null; document.querySelectorAll('.sort-zone').forEach(function(z){ z.classList.remove('targeted'); }); }}function updateSortScore() { var sc = document.getElementById('sort-score'); var fb = document.getElementById('sort-feedback'); sc.textContent = sortCorrect + ' of 10 documents correctly filed'; if (sortCorrect === 10) { fb.className = 'sort-feedback show all-ok'; fb.textContent = 'Excellent work! All 10 documents are filed in the correct zone. You have demonstrated a solid understanding of the DIA TMF Reference Model structure.'; } else if (sortCorrect >= 6) { fb.className = 'sort-feedback show partial'; fb.textContent = 'Good progress. Keep going — refer back to the zone descriptions above if you are unsure where a document belongs.'; }}function resetSort() { sortCorrect = 0; selectedDoc = null; // restore chips to pool var pool = document.getElementById('pool'); document.querySelectorAll('.sort-chip').forEach(function(c){ c.className = 'sort-chip'; c.onclick = function(){ selectChip(this); }; pool.appendChild(c); }); // clear zone bodies for (var i = 1; i <= 6; i++) { document.getElementById('szb-' + i).innerHTML = ''; document.getElementById('sz-' + i).classList.remove('targeted'); } document.getElementById('sort-score').textContent = ''; document.getElementById('sort-feedback').className = 'sort-feedback';}/* ── ISF INSPECTOR ── */function runInspection() { document.getElementById('finding-list').classList.add('show'); document.querySelector('.btn-inspect').textContent = 'Findings Generated'; document.querySelector('.btn-inspect').disabled = true;}/* ── QUIZ ── */var cur = 1, score = 0, done = {}, total = 5;var msgs = [ 'Keep going. Review the six zones and try again.', 'Good effort. A few more zones to review.', 'Solid work. Check the areas you missed.', 'Almost perfect. One more review and you will have it.', 'Excellent. You have a strong grasp of the DIA TMF Reference Model.', 'Perfect score. Outstanding.'];function pick(el, correct) { if (done[cur]) return; done[cur] = true; var allOpts = el.closest('.opts').querySelectorAll('.opt'); allOpts.forEach(function(o){ o.classList.add('locked'); }); if (correct) { el.classList.add('correct'); score++; document.getElementById('q-score').textContent = 'Score: ' + score; } else { el.classList.add('wrong'); allOpts.forEach(function(o){ if (!o.classList.contains('wrong')) { var f = o.querySelector('.opt-fb'); if (f && f.textContent.indexOf('Correct') === 0) o.classList.add('correct'); } }); } var nb = document.getElementById('nb-' + cur); if (nb) nb.disabled = false; document.getElementById('prog-fill').style.width = ((Object.keys(done).length / total) * 100) + '%';}function nextQ(from) { document.getElementById('qb-'+from).classList.remove('active'); document.getElementById('qb-'+(from+1)).classList.add('active'); cur = from+1; document.getElementById('q-counter').textContent = 'Question '+cur+' of '+total;}function prevQ(from) { document.getElementById('qb-'+from).classList.remove('active'); document.getElementById('qb-'+(from-1)).classList.add('active'); cur = from-1; document.getElementById('q-counter').textContent = 'Question '+cur+' of '+total;}function finishQ() { document.getElementById('qb-5').classList.remove('active'); document.getElementById('q-result').classList.add('show'); document.getElementById('res-score').innerHTML = score+'<span> / 5</span>'; document.getElementById('res-msg').textContent = msgs[score]; document.getElementById('prog-fill').style.width = '100%'; document.getElementById('q-counter').textContent = 'Complete';}function retryQ() { score=0; cur=1; done={}; for(var i=1;i<=total;i++){ var b=document.getElementById('qb-'+i); b.querySelectorAll('.opt').forEach(function(o){ o.className='opt'; var oc=o.getAttribute('onclick'); if(oc){(function(el,code){el.onclick=function(){eval(code);};})(o,oc);} }); b.classList.remove('active'); var nb=document.getElementById('nb-'+i); if(nb) nb.disabled=true; } document.getElementById('qb-1').classList.add('active'); document.getElementById('q-result').classList.remove('show'); document.getElementById('res-score').innerHTML='0<span> / 5</span>'; document.getElementById('q-score').textContent='Score: 0'; document.getElementById('q-counter').textContent='Question 1 of 5'; document.getElementById('prog-fill').style.width='0%';}[/tcb-script]

2.2 The DIA TMF Reference Model

You must be logged in to access this course